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Abstract
Purpose: Depression is common in primary care but often under-treated. Personal experiences with depression can affect
adherence to therapy, but the effect of vicarious experience is unstudied. We sought to evaluate the association between a
patient’s vicarious experiences with depression (those of friends or family) and treatment preferences for depressive
symptoms.
Methods: We sampled 1054 English and/or Spanish speaking adult subjects from July through December 2008, randomly
selected from the 2008 California Behavioral Risk Factor Survey System, regarding depressive symptoms and treatment
preferences. We then constructed a unidimensional scale using item analysis that reflects attitudes about antidepressant
pharmacotherapy. This became the dependent variable in linear regression analyses to examine the association between
vicarious experiences and treatment preferences for depressive symptoms.
Results: Our sample was 68% female, 91% white, and 13% Hispanic. Age ranged from 18–94 years. Mean PHQ-9 score was
4.3; 14.5% of respondents had a PHQ-9 score .9.0, consistent with active depressive symptoms. Analyses controlling for
current depression symptoms and socio-demographic factors found that in patients both with (coefficient 1.08, p=0.03)
and without (coefficient 0.77, p=0.03) a personal history of depression, having a vicarious experience (family and friend,
respectively) with depression is associated with a more favorable attitude towards antidepressant medications.
Conclusions: Patients with vicarious experiences of depression express more acceptance of pharmacotherapy. Conversely,
patients lacking vicarious experiences of depression have more negative attitudes towards antidepressants. When
discussing treatment with patients, clinicians should inquire about vicarious experiences of depression. This information
may identify patients at greater risk for non-adherence and lead to more tailored patient-specific education about
treatment.
Citation: Berkowitz SA, Bell RA, Kravitz RL, Feldman MD (2012) Vicarious Experience Affects Patients’ Treatment Preferences for Depression. PLoS ONE 7(2):
e31269. doi:10.1371/journal.pone.0031269
Editor: Vaughan Bell, King’s College London, United Kingdom
Received September 22, 2011; Accepted January 5, 2012; Published February 21, 2012
Copyright:  2012 Berkowitz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded with support from grants # R01MH79387 and K24MH72756 from the National Institute of Mental Health (RLK, PI). This work was
also supported by a University of California San Francisco Training in Clinical Research Grant (SAB). The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Seth.Berkowitz@ucsf.edu
Introduction
Depression is common in primary care but often goes
unrecognized and under-treated, with only one-fifth of patients
receiving guideline concordant care [1]. Even when the diagnosis
is made and treatment is initiated, as few as 25% of patients
adhere to their prescribed antidepressants [1]. Low adherence to
effective therapies contributes to needless patient suffering, and
results in wasted time and health care expenditures.
Prior studies have examined the predictors of poor adherence
[2,3,4,5] and have tested various interventions aimed at improving
patient adherence with antidepressant treatment [1,6]. Notably,
collaborative care models [7,8] have demonstrated benefit by
intervening on both clinician and patient level barriers to
adherence. In spite of these gains, adherence to antidepressant
treatment for most patients remains inadequate. Primary care
physicians need better tools to identify patient attitudes and
preferences for treatment that can then inform strategies for
patient-specific education about antidepressants. Treatment strat-
egies that incorporate patient preferences increase the likelihood
that a patient will enter treatment, adhere to prescribed regimens,
[9] and show clinical benefit [10,11]. The determinants of patient
treatment preferences for depression, however, are less well
studied.
Learning theory suggests that a patient’s positive past
experience with depression treatment should increase motivation
to seek the same or similar treatment [12]. Similarly, social
cognitive theory predicts that successfully accomplishing a task
should boost self-efficacy to accomplish similar tasks in the future
[13,14,15]. Moreover, social cognitive theory posits that vicarious
experience has similar effects on self-efficacy. In this context, we
are considering vicarious experience to be the experience,
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depression. Our group reported previously that physicians’
vicarious experiences with depression treatment influence their
attitudes and management [16,17]. In this study, we examined
whether patients’ vicarious experiences with depression treatment,
i.e., having a close friend or family member who had undergone
treatment for depression, would lead to a more favorable attitude
towards treatment.
This study was approved by the University of California, Davis,
Office of Research, Institutional Review Board (IRB).
Methods
Ethics Statement
All co-authors of this study affirm that the research was
conducted in accordance with the principles expressed in the
Declaration of Helsinki. Approval to conduct this research was
granted by the University of California, Davis, Office of Research,
Institutional Review Board (IRB) and the University of California,
San Francisco Committee on Human Research (CHR). Informed
consent was obtained for all participants.
We conducted a telephone follow-up of 1054 English and
Spanish speaking adult subjects from July through December
2008, randomly selected from the pool of respondents who had
completed the 2008 California Behavioral Risk Factor Survey
System (BRFSS). The methodology of the BRFSS has been
reported elsewhere [18]. Because the focus of the current survey
was on attitudes toward and experience with depression, subjects
with a history of depression were over-sampled (approximately
threefold) to yield an adequate sample size for those with a
depression history. Respondents were asked a set of questions
about their depression-related beliefs. From these responses we
constructed an outcome measure of attitude towards antidepres-
sant therapy based on 6 items (Cronbach’s alpha=.78) (Appendix
S1: Item Analysis for Outcome Variable). These items were
selected based on a factorial analysis demonstrating unidimen-
sionality, with all items having factor loadings $.65. This outcome
variable had possible scores from 6 to 30, with a higher value
representing a more positive attitude towards antidepressants.
Respondents were also asked if they had ever been treated for
depression and completed the PHQ-9, a measure of current
depressive symptoms [19]. Those individuals who were undergo-
ing treatment at the time of the survey or had ever been treated for
depression in the past were asked to rate the success of their
treatment on a 3-point scale (1=not very successful, 2=somewhat
successful, 3=very successful). Vicarious experiences with depres-
sion were assessed with two questions about whether the
respondent knew of a friend or family member who had been
treated for depression. Responses to these items were coded
dichotomously (no or yes).
Standard demographic variables were assessed to characterize
the sample and as statistical controls. These included gender, age,
race (nonwhite/white), Hispanic cultural identification, education,
income, and relationship status. Healthcare status was addressed
by asking if the respondent had health insurance and a regular
source of primary care. Descriptive statistics were used to
characterize the sample. Because presumably patients who have
a personal history of depression think about treatment from a
fundamentally different perspective than those who do not,
separate linear regression analyses were carried out for individuals
with versus without a history of depression to evaluate the
relationship of having a friend or family member with a depression
history on attitudes toward antidepressant treatment. Analyses
were performed using STATA 11.1 (College Station, TX).
Results
Table 1 reports sample demographic and health characteristics.
Our sample was 68% female, 91% white, and 13% Hispanic
(patients could self-identify as both white and Hispanic).
Respondents ranged in age from 18–94 (mean: 56.4 years). A
majority were married or were in a committed relationship (55%);
52% had graduated from college, and 42% had an annual
household income under $50,000/year. Almost half of respon-
dents (45%) had been treated for depression and 21% were
undergoing treatment at the time of the survey. Many respondents
reported knowing a friend (64%) or family member (53%) who
had undergone treatment for depression. Most had health
insurance (93%) and a regular source of health care (88%). The
mean PHQ-9 score was 4.33. Approximately 15% of respondents
had a PHQ-9 score .9.0 at the time of the survey, consistent with
active depressive symptoms [19].
Separate analyses were carried out for respondents with versus
without a personal history of depression. In both analyses, we
controlled for current depression symptoms and socio-demograph-
Table 1. Demographics and Health Characteristics.
Respondent Characteristic % N
DEMOGRAPHIC MEASURES
Female 67.7 714
White Race 90.7 954
Hispanic Identification 12.7 134
Age
18–29 4.5 47
30–39 9.2 97
40–49 19.6 207
50–59 22.9 241
$60 43.8 461
Married or Partnered 54.8 578
Education
H.S. or Less 18.1 191
Some College/Technical School 29.6 312
College Graduate 52.2 550
Household Income
Under $20,000 15.6 164
$20,000–$34,999 13.9 146
$35,000–$49,999 12.3 130
$50,000–$74,999 16.2 171
$75,000–$100,000 17.3 182
.$100,000 22.1 233
Unsure/Declined To Answer 2.7 28
DEPRESSION-RELATED MEASURES
Ever Treated for Depression 45.1 475
Currently Under Treatment for Depression 21.6 228
Has Friend Treated for Depression 64.3 670
Has Family Member Treated For Depression 52.7 555
Has Health Insurance 93.7 988
Regular Source of Primary Care 78.7 830
PHQ-9 Score .91 4 . 5 1 5 3
doi:10.1371/journal.pone.0031269.t001
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without (coefficient 0.96, p=0.005) a personal history of
depression, having a vicarious experience with depression, that
is, knowing a friend or family member treated for depression, was
associated with a more favorable attitude towards antidepressant
medications.
To further delineate the relationship between vicarious
experience and treatment preferences, we then performed a more
detailed regression to examine separately the influence of friend
and family experience. Results are presented in table 2. For
respondents with a personal history of depression, having a family
member who had been treated for depression was associated with
having a positive attitude toward antidepressant medications
(coefficient 1.08, p=0.03). However, among respondents with no
personal history of depression, having a friend who had been
treated for depression was associated with having a positive
attitude toward antidepressant medication (coefficient 0.77,
p=0.03). Additionally, a history of prior treatment with
antidepressant medication is strongly associated with having a
more favorable attitude to antidepressants. Interestingly, a higher
PHQ-9 score is negatively associated with attitudes towards anti-
depressants, suggesting that those who are more depressed are less
favorably inclined towards medication.
Discussion
This investigation suggests that having a vicarious experience
with depression may lead to a more positive attitude towards
treatment with antidepressant medications. Specifically, having a
family member who had been treated for depression was
associated with positive attitudes toward antidepressants for
respondents with a history of depression. In contrast, for
respondents with no history of depression treatment, having a
friend with a history of depression was associated with positive
attitudes toward antidepressant medications. These findings
support our hypothesis, based on learning and social cognitive
theory, that both personal past experiences and the experiences of
others can significantly affected attitudes towards treatment.
Patients who have taken antidepressant medication in the past
have a highly favorable attitude towards antidepressants. This is
consistent with other work which has shown an favorable attitude
towards treatment for those who have been prescribed or are
currently taking anti-depressants [20],. Prior research suggests that
those with positive attitudes towards antidepressants are more
likely to be adherent [21] and that as treatments more closely
match patient preferences, adherence is increased [10].
Interestingly, we also found that higher scores on the PHQ-9
are associated with more negative attitudes. As past work has
shown that those with negative attitudes towards treatment have
decreased adherence [22], this suggests that those who might
benefit most from treatment, those most depressed [23], might be
a group at particular risk for non-adherence. Every effort should
be made to engage these patients in evidence based therapies.
Busy clinicians, especially in primary care, often face multiple
demands for their time. We feel the ideal time to discuss vicarious
experiences with depression treatment with a patient is when a
clinician is considering initiation of treatment. This can be
incorporated into routine counseling and anticipatory guidance
around starting a new medication. Open-ended statements
encourage patients to share details about their own experiences.
For example, clinicians could say ‘‘Do you know anyone who has
had depression?’’ or ‘‘Tell me about people you have known with
depression’’. Once obtained, this information can help identify
patients at greater risk for non-adherence and be used to tailor
patient-specific education about treatment.
It is curious that patients with a personal history of depression
are influenced differently by their vicarious experience compared
to those with no personal history. Patients with a personal and
family history of depression may view their condition as more
attributable to heredity and thus be open to a biomedical
perspective, one that views pharmacological treatment favorably.
In contrast, a person with no history of depression may see the
depression experiences of a friend as being more informative than
the experience of a family member. It should be noted, however,
that although the association between attitudes toward antide-
pressant medications and having a family member who had been
treated for depression for this group of respondents missed
statistical significance, the relationship was in the anticipated
direction. How vicarious experience mediates attitudes toward
treatment for depressive symptoms is unknown. One possible
mechanism may lie through the reduction of stigma. Prior studies
of vicarious experience have noted that people who have a friend
or family member with depression rate lower on measures of
stigma (such as regarding depression as a ‘real’ illness, or feeling
Table 2. Results of linear regression analyses predicting attitude toward antidepressants with subgroups of vicarious experience
of depression for respondents with and without a history of depression.
Covariate Coeff. 95% CI P
HISTORY OF DEPRESSION (n=451)
Has Friend With History of Depression 0.16 (20.94, 1.27) 0.77
Has Family Member With History of Depression 1.08 (0.08, 2.07) 0.03
Past history of medication use 3.00 (1.98, 4.03) ,0.0001
PHQ-9 Score 20.07 (20.14, 20.001) 0.045
NO HISTORY OF DEPRESSION (n=550)
Has Friend With History of Depression 0.77 (0.06, 1.48) 0.03
Has Family Member With History of Depression 0.47 (20.25, 1.21) 0.20
PHQ-9 Score 20.20 (20.31, 20.10) ,0.0001
Note: Results have been adjusted for the following control variables: Age, PHQ-9 score, income, educational attainment, gender, ethnicity, availability of primary care,
and relationship status.
A positive coefficient represents a more positive attitude towards antidepressant medications.
Number of observations in each regression model differs slightly from demographic data due to missing responses.
doi:10.1371/journal.pone.0031269.t002
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than those without such an experience [24].
This study has several limitations. First, our outcome was a
psychometric measure of attitudes towards antidepressants derived
from survey data. It was not validated or assessed for reliability in
other populations, and was not a clinical measure. Thus we cannot
be sure how the associated positive regard will translate in the
office setting. Second, our data are cross-sectional and thus can
demonstrate an association between vicarious experience and
treatment attitudes, but not a causal link. Third, compared to the
BRFSS survey sample as a whole [25], which is representative of
California, our sample was generally older and had higher income
than the general population. Although we controlled for age and
income in our analysis, this may limit generalizability to other
settings.
In summary, patients who lack personal or vicarious experiences
with depression tend to have negative attitudes towards antide-
pressants. Conversely, having such experience may facilitate
acceptance of pharmacotherapy. Future research should focus
on strategies that utilize knowledge of patient characteristics to
boost treatment adherence.
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